Growth Metrics

GoodRx Holdings (GDRX) Receivables - Net (2019 - 2026)

GoodRx Holdings' Receivables - Net history spans 7 years, with the latest figure at $235.7 million for Q4 2025.

  • On a quarterly basis, Receivables - Net rose 61.54% to $235.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $235.7 million, a 61.54% increase, with the full-year FY2025 number at $235.7 million, up 61.54% from a year prior.
  • Receivables - Net hit $235.7 million in Q4 2025 for GoodRx Holdings, up from $203.7 million in the prior quarter.
  • Over the last five years, Receivables - Net for GDRX hit a ceiling of $235.7 million in Q4 2025 and a floor of $74.4 million in Q1 2021.
  • Historically, Receivables - Net has averaged $136.9 million across 5 years, with a median of $123.3 million in 2022.
  • Biggest five-year swings in Receivables - Net: soared 71.81% in 2021 and later decreased 5.55% in 2023.
  • Tracing GDRX's Receivables - Net over 5 years: stood at $118.1 million in 2021, then fell by 0.8% to $117.1 million in 2022, then increased by 22.59% to $143.6 million in 2023, then grew by 1.62% to $145.9 million in 2024, then surged by 61.54% to $235.7 million in 2025.
  • Business Quant data shows Receivables - Net for GDRX at $235.7 million in Q4 2025, $203.7 million in Q3 2025, and $189.0 million in Q2 2025.